Renal Cancers Completed Phase 1 / 2 Trials for Aldesleukin (DB00041)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003585Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney CancerTreatment
NCT00588913Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung MetastasesTreatment
NCT01218867CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic CancerTreatment